Multicenter Randomized Phase 2 Clinical Trial of a Recombinant Human Endostatin Adenovirus in Patients with Advanced Head and Neck Carcinoma

A randomized, open-label, phase 2, multicenter clinical trial was conducted to evaluate the efficacy and safety of the addition of a recombinant human endostatin adenovirus (E10A) to cisplatin and paclitaxel in patients with advanced head and neck squamous cell carcinoma or nasopharyngeal carcinoma....

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Ye, Wen, Liu, Ranyi, Pan, Changchuan, Jiang, Wenqi, Zhang, Li, Guan, Zhongzhen, Wu, Jiangxue, Ying, Xiaofang, Li, Lixia, Li, Su, Tan, Wen, Zeng, Musheng, Kang, Tiebang, Liu, Qing, Thomas, George R, Huang, Manli, Deng, Wuguo, Huang, Wenlin
Формат: Artigo
Язык:Inglês
Опубликовано: Nature Publishing Group 2014
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4048902/
https://ncbi.nlm.nih.gov/pubmed/24662947
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2014.53
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы